Trial · NCT05346874
Neoadjuvant TACiE in Locally Advanced Gastric Cancer
NCT05346874, Phase 2, Unknown, Shanghai Zhongshan Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Neoadjuvant TACiE in Locally Advanced Gastric Cancer. Trials, record NCT05346874. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05346874
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Neoadjuvant TACiE in Locally Advanced Gastric Cancer
- NCT number
- NCT05346874
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 37 participants, estimated
- Lead sponsor
- Shanghai Zhongshan Hospital
- Conditions
- Gastric Cancer
- Interventions
- Oxaliplatin, Teysuno, Transarterial chemoembolization (TACE)
- First posted
- 2022-04-26
- Last updated
- 2022-05-26
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pathological complete response (pCR) rate | two weeks after surgery | The percentage of patients found no tumor residual in primary tumor and resected lymph nodes. |
| Secondary | Pathological response rate (pRR) | two weeks after surgery | The percentage of patients found less than 10% tumor residual in primary tumor. |
| Secondary | Objective response rate (ORR) | up to 3 months | The percentage of patients found complete response or partial response to preoperative therapy according to RECIST v1.1. |
| Secondary | The incidence of treatment emergent adverse events. | up to 1 month after surgery. | Safety |
| Secondary | Overall survival | From date of enrollment until the date of death from any cause, assessed up to 36 months | The time from enrollment to death caused by any causes or censor. |
| Secondary | Progressive free survival | From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 36 months | The time from enrollment to tumor progression, death or censor. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers13
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05346874
GET https://conductscience.org/api/trials/v1/NCT05346874/registered